2m 2m 2m 2m 2m 2m 2m
Pacific Bio CA (PACB)
NASDAQ
$2.07-$0.07 (-3.27%)
Price as of Oct 22, 2026 7:05 PM EDT- $665.2MMarket Cap
- 16.30%1-Year Change
- Medical DevicesIndustry
Pacific Bio CA (PACB)
$2.07-$0.07 (-3.27%)
PACB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.14 | ||
Change | +$0.18 (+9.18%) | ||
Open | $1.97 | ||
High | $2.19 | ||
Low | $1.92 | ||
Previous Close | $1.96 | ||
Volume | 13,503,569 | ||
30-Day Average Volume | 19,124,834 | ||
1-Week Change | 7.54% | ||
1-Month Change | 57.35% | ||
1-Year Change | 16.30% | ||
3-Year Change | -71.04% | ||
5-Year Change | -91.63% | ||
Fundamentals | |||
Shares Outstanding | 310.8M | ||
Total Assets | $751.9M | ||
Market Cap | $665.2M | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | $33.0M | ||
Net Income | -$44.7M | ||
Free Cash Flow | -$37.1M | ||
EBIT | -$42.9M | ||
EBITDA | -$39.4M | ||
Net Working Capital | $269.8M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -32 | ||
Enterprise Value/Revenue | 38 | ||
P/B | -20 | ||
P/E | -15 | ||
PEG | 0 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue